Skip to main content
Clinical Trials/CTRI/2024/03/064152
CTRI/2024/03/064152
Not yet recruiting
未知

PRECEDE: The Pancreatic Cancer Early Detection Consortium - Precede

Arbor research collaborative for Health0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C759- Malignant neoplasm of endocrine gland, unspecified
Sponsor
Arbor research collaborative for Health
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals from the following groups who present for clinical evaluation and assessment of PDAC risk at Max Super speciality hospital can be offered participation in the PRECEDE database:
  • Individuals without history of PDAC meeting any of the following criteria:
  • 1\. 2\+ relatives with PDAC on same side of family where 2 affected are first degree related to each other and at least 1 affected is first degree related to subject; age 50\+ or \=10 years younger than earliest PDAC in family at time of diagnosis.
  • 2\. 2 affected first degree relatives with PDAC; age 50\+ or 10 years younger than earliest PDAC in family
  • 3\. BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, EPCAM pathogenic or likely pathogenic variant AND 1 first or second degree relative with PDAC; age 50\+ or 10 years younger than earliest PDAC in family
  • 4\. Familial Atypical Moles and Malignant Melanoma (FAMMM) with pathogenic or likely pathogenic CDKN2A variant; age 40\+
  • 5\. Peutz\-Jegher syndrome with STK11 pathogenic or likely pathogenic variant; age 35\+
  • 6\. Hereditary pancreatitis with PRSS1 pathogenic or likely pathogenic variant and history of pancreatitis; age 40\+
  • Individuals without history of PDAC meeting any of the following criteria:
  • 1\. ATM, BRCA1, BRCA2, or PALB2 pathogenic or likely pathogenic variant regardless of family history, age 50\+

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials